40.45 -0.13 (-0.32%)
After hours: 6:31PM EST
|Bid||40.45 x 1100|
|Ask||43.00 x 900|
|Day's Range||40.46 - 42.58|
|52 Week Range||40.46 - 56.00|
|Beta (5Y Monthly)||1.03|
|PE Ratio (TTM)||23.87|
|Forward Dividend & Yield||1.80 (4.28%)|
|Ex-Dividend Date||Mar 29, 2020|
|1y Target Est||58.28|
Nutrien Ltd. (TSX and NYSE: NTR) (Nutrien) today announced that the Toronto Stock Exchange (TSX) has accepted Nutrien's notice to commence a normal course issuer bid (NCIB) to purchase up to five percent of its outstanding common shares.
(Bloomberg) -- There’s at least one commodity that may benefit from China’s outbreak of coronavirus: phosphate.The outbreak is expected to cause a two million-ton shortfall of the fertilizer ingredient in China as plants curtail production and transport is hindered, said Joc O’Rourke, chief executive officer of of Mosaic Co., the world’s largest producer. Much of the nation’s phosphate production is in Hubei province, the center of the outbreak, and the supply drop is expected to further tighten the market, according to the company.Mosaic shares gained as much as 4.8% in New York on Thursday, the most in two weeks.“The expectation is there won’t really be a demand impact, but it will have a supply impact,” Jonas Oxgaard, an analyst at Sanford C. Bernstein, said by telephone. “It’s the best of both worlds for U.S. fertilizer companies.”The tightening phosphate market comes as the worst of the fertilizer downturn may be over. After extreme weather led to poor fertilizer demand last year, U.S. corn plantings are expected to rise to the highest in four years while soybean plantings also rise, the U.S. Department of Agriculture said Thursday.Nutrien Ltd. rose as much as 2.3%, while CF Industries Holdings Inc. gained 3.1%.“The market is screaming ‘bottom’,” Scotiabank’s Ben Isaacson said in a note Wednesday, noting that Nutrien’s share price rose even after its quarterly earnings and guidance missed consensus.\--With assistance from Aoyon Ashraf.To contact the reporter on this story: Jen Skerritt in Winnipeg at firstname.lastname@example.orgTo contact the editors responsible for this story: James Attwood at email@example.com, Millie MunshiFor more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2020 Bloomberg L.P.
Nutrien Ltd. (Nutrien) (NYSE, TSX: NTR) announced today that its Board of Directors has declared a quarterly dividend of US$0.45 per share payable April 16, 2020 to shareholders of record on March 31, 2020.
Nutrien said it expects adjusted earnings of $1.90 per share to $2.60 per share, below analysts' expectations of $2.73 per share. The company, however, said the recent progress in trade relations between the world's two largest economies has led to positive sentiment among U.S. growers as agricultural exports to China are expected to improve significantly both in the short and medium term. The company reported a net loss from continuing operations of $48 million, or 8 cents per share, in the fourth quarter ended Dec. 31, compared with a profit of $296 million, or 48 cents per share, a year earlier.
Nutrien Ltd. (Nutrien) (NYSE, TSX: NTR) announced today its 2019 fourth-quarter and full year 2019 results, with a net loss from continuing operations of $48 million ($0.08 diluted loss per share) in the fourth quarter of 2019. Fourth-quarter adjusted net earnings was $0.09 per share and adjusted EBITDA was $664 million. Adjusted net earnings (total and per share amounts) and adjusted EBITDA, together with the related annual guidance, Potash adjusted EBITDA, free cash flow and free cash flow including changes in non-cash working capital are non-IFRS financial measures. See the "Non-IFRS Financial Measures" section for further information.
Nutrien Ltd. (Nutrien) (NYSE, TSX: NTR) announced today that Mr. Chuck Magro, Nutrien’s President and CEO, will be presenting at the Bank of America 2020 Global Agriculture and Materials Conference in Fort Lauderdale, FL., on Wednesday, February 26, 2020 at 10:00 a.m. EST.
Nutrien Ltd. (Nutrien) (NYSE, TSX: NTR) announced today that Mr. Chuck Magro, Nutrien’s President and CEO, will be presenting at the BMO 29th Global Metals & Mining Conference in Hollywood, FL., on Tuesday, February 25, 2020 at 1:30 p.m. EST.
Nutrien (NTR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Passive investing in an index fund is a good way to ensure your own returns roughly match the overall market. But if...
Nutrien Ltd. (Nutrien) (NYSE, TSX: NTR) plans to release fourth quarter earnings results on Tuesday, February 18, 2020, after market close. Nutrien will host a conference call the following day, Wednesday, February 19, 2020 at 9:00 a.m. CST (10:00 a.m. EST) to discuss and answer investor questions on fourth quarter results and the outlook.
Nutrien Ltd. (Nutrien) (NYSE, TSX: NTR) announced today that Mr. Mike Frank, Nutrien’s Executive Vice President and CEO of Retail, will be presenting at CIBC’s 23rd Annual Western Institutional Investor Conference in Banff, AB., on Wednesday, January 29, 2020 at 3:50 p.m. MST.
Investors are always on the lookout for stocks poised to deliver hefty returns. While it’s true anyone can measure a stock’s potential by themselves, as in any field, the pros probably have the best tools at hand to assess the choices the market presents.This is where we turn to the analysts on the Street. Some of the best amongst them are currently employed by famed investment firm RBC Capital, as the company sits at the top of the heap of TipRanks’ Top Performing Research Firms.The company, like many in the industry, begins a new year by reassessing the future potential of stocks under its coverage.With this in mind, we decided to take a look at three tickers the investment firm thinks have the potential to take off in 2020. All currently have Buy consensus ratings from the Street and all, according to RBC analysts, have the potential for gains in the magnitude of at least 25% in the year ahead. Let’s check them out.Constellation Brands (STZ)Cannabis stocks took a heavy beating in 2019, with some companies losing a significant amount of value along the way (Tilray, Aurora and Cronos come to mind). Though not strictly a cannabis stock, with its main business driven by the alcoholic beverage industry, Constellation’s massive investment in Canopy Growth, which boasts the largest market cap among Canadian cannabis producers, has positioned it at the forefront of the struggling pot industry.Despite Canopy’s plethora of struggles last year (consecutive quarters of disappointing results, CEO Bruce Linton being removed and replaced with a Constellation appointment), Constellation’s recent F3Q20 report beat expectations on most fronts. Sales of $2 billion beat the estimate’s $1.95 billion. More impressively, EPS came in at $2.14, beating the consensus’s call of $1.84. The most cheer was provided by the company’s beer business, with Constellation’s Modelo Especial brand up by almost 15%, and cementing itself as the fourth-largest beer brand in the US. The company also raised its guidance of EPS for the whole year, too, from $9-$9.20 up to $9.45-$9.55.The positive print has RBC’s Nik Modi betting on STZ. Modi reiterated an Outperform rating on the stock alongside a price target of $250, which implies 32% upside potential from current levels. (To watch Modi’s track record, click here)The 5-star analyst said, “The beer business is fine and should benefit from the Corona Seltzer launch (expected beginning of FY'21 - March 2020). W&S remains messy due to the divestiture, but there are some green shoots that suggest the portfolio will be in a better place post-divestiture. Canopy is still an overhang, but with David Klein in place, we think costs will come under control. All in all, a lot of noise, but we are nearing visibility into 2021 earnings power.”The Street is currently split down the middle with regards to the alcohol producer’s prospects. 6 Buys and 6 Hold ratings coalesce into a Moderate Buy consensus rating. The bulls, though, have the edge as the average price target comes in at $223 and indicates potential gains of 18% over the coming months. (See Constellation Brands stock analysis on TipRanks)Nutrien Ltd (NTR)A big name in the agricultural industry, Nutrien was formed in January 2018 following the huge merger of Agrium and PotashCorp. The company is the world’s largest agricultural input retailer and fertilizer producer.Technological advancements are an increasingly important growth catalyst in many different industries, and the agricultural sector is no different. Nutrien has been maneuvering itself into a leading position in what is known as digital agriculture. The company’s digital platform was launched almost 2 years ago and provides farmers with data on climate and weather conditions to assist in the process of planting, fertilizing and harvesting. The platform met with immediate success and it took only 6 months from its launch for more than 50% of the company’s North American retail sales customers to start making use of it.Nutrien has also been busy on the acquisition front, the latest of which was only announced last week. The company agreed to purchase Brazilian Ag retailer Agrosema Comercial Agricola, an important player in the Brazilian agricultural industry. The purchase comes hot on the heels of several other acquisitions since the launch of its digital platform and RBC’s Andrew Wong thinks there is more to come.The analyst said, “We believe the company will continue the roll-up strategy in North America, spending ~$300–500M annually on accretive acquisitions. In Brazil, we expect Nutrien to gradually build up a base through acquisitions that may be priced above typical valuations (due to less natural synergies), but eventually build a business model similar to the highly successful North American business. The Wholesale segment is working on several cost savings and expansion projects that should result in lower potash production costs and higher nitrogen volumes.”To this end, Wong kept his bullish call on Nutrien with an Outperform rating and price target of $60. The figure represents potential gains in the shape of 27%. (To watch Wong’s track record, click here)What side of the field does the Street stand on regarding the fertilizer producer’s potential, then? On the growing side, as it happens. A Strong Buy consensus rating breaks down into 6 Buys and 2 Holds. The average price target comes in at $56.60 and therefore indicates room for growth of another 20%. (See Nutrien stock analysis on TipRanks)Mosaic Co (MOS)A fellow giant in the agricultural industry is the US’s largest producer of potash and phosphate fertilizer, the Mosaic Company.Mosaic had a difficult 2019 with its share price losing almost 25% over the year. Slipping margins, bad weather and the effect of the US and China trade war all played their part in suppressing the share price. The recent easing of the trading tensions saw Mosaic’s stock climb out of the doldrums in December; China is one of the company’s biggest markets and its willingness to buy more US agricultural products is a part of the phase one trade deal, and could provide a boon for US fertilizer producers.Like Nutrien, Mosaic has also been busy in Brazil; in 2018, the company acquired Vale’s Brazil-based phosphate and potash business. By the end of last year it had run-rate synergies of $275 million, with the company targeting a further $200 million EBITDA benefit from the business by the end of 2022.Despite a disappointing 2019, Andrew Wong, who also covers MOS, believes the phosphate markets are “close to bottoming." The analyst further added, “Mosaic provides strong leverage to the potash and phosphate markets, and we believe it would be an ideal investment in a commodity upside scenario. The acquisition of production and distribution assets in Brazil further enhances the company’s exposure to the fastest-growing agriculture market and provides significant synergy potential.”With this in mind, Wong reiterates an Outperform rating on the potash producer, along with a $26 price target, which implies possible upside of 26%.With 6 Buys, 1 Hold and 1 Sell, Mosiac receives a Moderate Buy consensus rating from the Street. If the average price target of $24.13 can be met, investors stand to pocket a 17% over the next 12 months. (See Mosaic stock analysis on TipRanks)
Investing in hedge funds can bring large profits, but it’s not for everybody, since hedge funds are available only for high-net-worth individuals. They generate significant returns for investors to justify their large fees and they allocate a lot of time and employ complex research processes to determine the best stocks to invest in. A particularly […]
(Bloomberg Opinion) -- Anglo American Plc is dabbling in creative M&A. Buying an English fertilizer project for just over $500 million, excluding debt, is more than manageable for a $35 billion mining giant that generated $1.3 billion in free cash flow in the first half of last year. It’s also a gamble on an unproven niche market that speaks to the paucity of large-scale acquisition options for cashed-up diggers.Anglo said on Wednesday it may bid for London-listed Sirius Minerals Plc, owner of a giant potash project under the North York Moors national park. The mine’s future has been in question since a funding plan collapsed last year, after Sirius was forced to pull a $500 million junk bond sale, making it impossible to unlock a $2.5 billion credit facility from JPMorgan Chase & Co.That makes this an opportunistic move by Chief Executive Officer Mark Cutifani. Anglo is offering 5.5 pence per share for a stock that traded at four times that less than a year ago. It’s an affordable option — Anglo can easily support both the cost of the initial deal and a development spend estimated at $300 million a year for the next two years.It’s a laudable effort at diversification too, away from South Africa, into a counter-cyclical commodity and a space the miner hasn’t been in since selling its niobium and phosphates business in Brazil in 2016. It’s also purchasing at a relatively low point for fertilizer ingredients — notable for an industry that in the past burned billions buying at the top.None of this means Anglo should press ahead with a firm offer.Anglo shareholders still bear bruises from its disastrous, peak-of-the-market Minas Rio deal – a Brazilian iron-ore project that was plagued by years of cost overruns and delays, and ultimately contributed to the departure of Cutifani’s predecessor. The $5 billion Quellaveco copper mine in Peru, meanwhile, which was supposed to prove Anglo’s ability to build from scratch, is still two years from production.Anglo argues the Sirius development is far more advanced than Minas Rio was. That’s true. But it will still require some $3 billion, by Sirius estimates, and a 37-kilometer (23-mile) tunnel under a national park, for a conveyor belt to take rock to port. A challenge, even with permits in hand.Investors should be far more worried about Anglo bosses’ willingness to bet on a project where demand for the end product — an alternative to traditional potassium-bearing minerals called polyhalite — is unproven, and prices are unclear. The selling point is that it combines several key nutrients along with potassium — magnesium, sulfur and calcium — and is low-chloride too, which matters for some crops. It’s unclear how those extras are valued, though.Only one company, Israel Chemicals Ltd., currently produces polyhalite, from one mine. Price estimates range from $100 to $200 per metric ton, making the economics difficult to calculate, including Sirius’s promised 50%-plus Ebitda margin.Polyhalite accounts for a tiny sliver of the wider potash market, even among low-chloride alternatives, largely because it contains far less potassium.That means the capacity of the Yorkshire mine dwarfs current demand. The polyhalite market amounts to less than one million tons a year, but the Yorkshire mine could produce 13 million tons. That’s a mighty step up, even accounting for the purchase agreements Sirius has already signed. Success will require building substantial new demand and clawing market share away from potash giants like Nutrien Ltd. With plentiful supply of standard potash in the medium term, that may be a challenge.There is some element of reassurance here. Even if it bids, Anglo won’t be committing to develop the mine, making this an option of sorts.That’s small consolation for investors, though, who will fret that cash-rich miners looking for growth — and wary of overspending on coveted metals like copper — will begin to experiment. Expect mixed results. To contact the author of this story: Clara Ferreira Marques at firstname.lastname@example.orgTo contact the editor responsible for this story: Matthew Brooker at email@example.comThis column does not necessarily reflect the opinion of the editorial board or Bloomberg LP and its owners.Clara Ferreira Marques is a Bloomberg Opinion columnist covering commodities and environmental, social and governance issues. Previously, she was an associate editor for Reuters Breakingviews, and editor and correspondent for Reuters in Singapore, India, the U.K., Italy and Russia.For more articles like this, please visit us at bloomberg.com/opinionSubscribe now to stay ahead with the most trusted business news source.©2020 Bloomberg L.P.
Dividend paying stocks like Nutrien Ltd. (TSE:NTR) tend to be popular with investors, and for good reason - some...
Nutrien Ltd. ("Nutrien") (NYSE, TSX: NTR) announced today that it has entered into a definitive agreement to purchase 100 percent of the equity of Agrosema Comercial Agricola Ltda. ("Agrosema"). Agrosema is an important Ag retailer in the southern Brazil crop input market with over 30 years of experience. Their annual sales are approximately US$60 million across 12 farm centers with approximately 200 employees servicing thousands of farm customers.
German potash and salt miner K+S said it was looking into selling stakes in its North American businesses because an ongoing cost cutting push would not yield enough savings to reach its debt reduction target. A company spokesman said K+S was considering selling a stake in its Bethune potash mine in Canada - which the company values at nearly 5 billion euros ($5.5 billion) - or bringing in an industry partner.
Does Nutrien Ltd. (NYSE:NTR) represent a good buying opportunity at the moment? Let’s quickly check the hedge fund interest towards the company. Hedge fund firms constantly search out bright intellectuals and highly-experienced employees and throw away millions of dollars on satellite photos and other research activities, so it is no wonder why they tend to […]
We are still in an overall bull market and many stocks that smart money investors were piling into surged through November 22nd. Among them, Facebook and Microsoft ranked among the top 3 picks and these stocks gained 52% and 49% respectively. Hedge funds' top 3 stock picks returned 39.1% this year and beat the S&P […]